China’s property prices in November indicated towards a continued moderation in overall prices but one that is led by the Tier 1 cities. This reflects government attempts to ease down on excessive price gains in the Tier 1 cities.
Also, markets are closely monitoring developments in the short term money market rates. The PBoC raised the 14-day reverse repo rate by 5 basis points today to 2.65 percent. This just tracked the 5 basis points hike last week for the other tenors, including the 7-day, 28-day, and the 1Y medium term rate, noted Commerzbank.
The Chinese central bank is expected to remain on the delivering theme. However, it is expected to undertake steps to guarantee ample liquidity to avert a liquidity crunch. For USD/CNY, there was not much reaction to the property data, stated Commerzbank.
At 18:00 GMT the FxWirePro's Hourly Strength Index of Japanese Yen was neutral at 18.0336, while the FxWirePro's Hourly Strength Index of US Dollar was slightly bearish at -52.0475. For more details on FxWirePro's Currency Strength Index, visit http://www.fxwirepro.com/currencyindex
FxWirePro launches Absolute Return Managed Program. For more details, visit http://www.fxwirepro.com/invest


China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Best Gold Stocks to Buy Now: AABB, GOLD, GDX
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



